Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease [NA]

View source ↗

Summary

This clinical trial aims to evaluate the safety and efficacy of IBS in patients with coronary artery disease. The study, sponsored by Biotyx Medical (Shenzhen) …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• IBS

Snippet

Sponsor: Biotyx Medical (Shenzhen) Co., Ltd. | Conditions: Coronary Artery Disease | NA | Status: ACTIVE_NOT_RECRUITING